347 related articles for article (PubMed ID: 19651206)
1. The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.
Martin LJ
Biochim Biophys Acta; 2010 Jan; 1802(1):186-97. PubMed ID: 19651206
[TBL] [Abstract][Full Text] [Related]
2. Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.
Martin LJ
IDrugs; 2010 Aug; 13(8):568-80. PubMed ID: 20721828
[TBL] [Abstract][Full Text] [Related]
3. The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice.
Martin LJ; Gertz B; Pan Y; Price AC; Molkentin JD; Chang Q
Exp Neurol; 2009 Aug; 218(2):333-46. PubMed ID: 19272377
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?
Muyderman H; Chen T
Br J Pharmacol; 2014 Apr; 171(8):2191-205. PubMed ID: 24148000
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial pathobiology in ALS.
Martin LJ
J Bioenerg Biomembr; 2011 Dec; 43(6):569-79. PubMed ID: 22083126
[TBL] [Abstract][Full Text] [Related]
6. Repetitive nerve stimulation transiently opens the mitochondrial permeability transition pore in motor nerve terminals of symptomatic mutant SOD1 mice.
Nguyen KT; Barrett JN; García-Chacón L; David G; Barrett EF
Neurobiol Dis; 2011 Jun; 42(3):381-90. PubMed ID: 21310237
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial pathobiology in Parkinson's disease and amyotrophic lateral sclerosis.
Martin LJ
J Alzheimers Dis; 2010; 20 Suppl 2():S335-56. PubMed ID: 20413846
[TBL] [Abstract][Full Text] [Related]
8. Biology of mitochondria in neurodegenerative diseases.
Martin LJ
Prog Mol Biol Transl Sci; 2012; 107():355-415. PubMed ID: 22482456
[TBL] [Abstract][Full Text] [Related]
9. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis.
Martin LJ
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1103-10. PubMed ID: 17146283
[TBL] [Abstract][Full Text] [Related]
10. GNX-4728, a novel small molecule drug inhibitor of mitochondrial permeability transition, is therapeutic in a mouse model of amyotrophic lateral sclerosis.
Martin LJ; Fancelli D; Wong M; Niedzwiecki M; Ballarini M; Plyte S; Chang Q
Front Cell Neurosci; 2014; 8():433. PubMed ID: 25565966
[TBL] [Abstract][Full Text] [Related]
11. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.
Martin LJ
Pharmaceuticals (Basel); 2010; 3(4):839-915. PubMed ID: 21258649
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction in amyotrophic lateral sclerosis.
Shi P; Gal J; Kwinter DM; Liu X; Zhu H
Biochim Biophys Acta; 2010 Jan; 1802(1):45-51. PubMed ID: 19715760
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration.
Martin LJ
Rev Neurosci; 2007; 18(2):115-36. PubMed ID: 17593875
[TBL] [Abstract][Full Text] [Related]
15. The role of insulin-like growth factor 1 in ALS cell and mouse models: A mitochondrial protector.
Wen D; Cui C; Duan W; Wang W; Wang Y; Liu Y; Li Z; Li C
Brain Res Bull; 2019 Jan; 144():1-13. PubMed ID: 30414993
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta.
Du H; Yan SS
Biochim Biophys Acta; 2010 Jan; 1802(1):198-204. PubMed ID: 19616093
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis.
Menzies FM; Cookson MR; Taylor RW; Turnbull DM; Chrzanowska-Lightowlers ZM; Dong L; Figlewicz DA; Shaw PJ
Brain; 2002 Jul; 125(Pt 7):1522-33. PubMed ID: 12077002
[TBL] [Abstract][Full Text] [Related]
18. Progressive Mitochondrial SOD1
Méndez-López I; Sancho-Bielsa FJ; Engel T; García AG; Padín JF
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360957
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of human mutated G93A SOD1 changes dynamics of the ER mitochondria calcium cycle specifically in mouse embryonic motor neurons.
Lautenschläger J; Prell T; Ruhmer J; Weidemann L; Witte OW; Grosskreutz J
Exp Neurol; 2013 Sep; 247():91-100. PubMed ID: 23578819
[TBL] [Abstract][Full Text] [Related]
20. HAX-1 regulates cyclophilin-D levels and mitochondria permeability transition pore in the heart.
Lam CK; Zhao W; Liu GS; Cai WF; Gardner G; Adly G; Kranias EG
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6466-75. PubMed ID: 26553996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
